Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Alterity Therapeutics's price to sales ratio was 73.6× on Aug 30, 2019, against 193.9× a year earlier. Over the last 3 years it ranged from 64.9× to 367.7×, with a median of 183.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Aug 30, 2019 | 73.6× | −6.7 |
| 2018 | Dec 31, 2018 | 80.4× | −188.0 |
| 2017 | Dec 29, 2017 | 268.3× | +127.7 |
| 2016 | Dec 30, 2016 | 140.6× | – |
See a number that looks wrong?